72
Views
5
CrossRef citations to date
0
Altmetric
Original Research

The Impact of Chronic Liver Disease on Postoperative Outcomes and Resource Utilization

, &
Pages 617-626 | Received 04 May 2019, Accepted 02 Oct 2019, Published online: 29 Oct 2019

References

  • Mokdad AA, Lopez AD, Shahraz S, et al. Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis. BMC Med. 2014;12(1):145. doi:10.1186/s12916-014-0145-y.
  • Stepanova M, De Avila L, Afendy M, et al. Direct and indirect economic burden of chronic liver disease in the United States. Clin Gastroenterol Hepatol. 2017;15(5):759–766 e5. doi:10.1016/j.cgh.2016.07.020.
  • de Goede B, Klitsie PJ, Lange JF, et al. Morbidity and mortality related to non-hepatic surgery in patients with liver cirrhosis: a systematic review. Best Pract Res Clin Gastroenterol. 2012;26(1):47–59. doi:10.1016/j.bpg.2012.01.010.
  • Bhangui P, Laurent A, Amathieu R, et al. Assessment of risk for non-hepatic surgery in cirrhotic patients. J Hepatol. 2012;57(4):874–884. doi:10.1016/j.jhep.2012.03.037.
  • Teh SH, Nagorney DM, Stevens SR, et al. Risk factors for mortality after surgery in patients with cirrhosis. Gastroenterology. 2007;132(4):1261–1269. doi:10.1053/j.gastro.2007.01.040.
  • Northup PG, Wanamaker RC, Lee VD, et al. Model for End-Stage Liver Disease (MELD) predicts nontransplant surgical mortality in patients with cirrhosis. Ann Surg. 2005;242(2):244–251. doi:10.1097/01.sla.0000171327.29262.e0.
  • Neeff H, Mariaskin D, Spangenberg H-C, et al. Perioperative mortality after non-hepatic general surgery in patients with liver cirrhosis: an analysis of 138 operations in the 2000s using Child and MELD scores. J Gastrointest Surg. 2011;15(1):1–11. doi:10.1007/s11605-010-1366-9.
  • Ziser A, Plevak DJ, Wiesner RH, et al. Morbidity and mortality in cirrhotic patients undergoing anesthesia and surgery. Anesthesiology. 1999;90(1):42–53. doi:10.1097/00000542-199901000-00008.
  • Csikesz NG, Nguyen LN, Tseng JF, et al. Nationwide volume and mortality after elective surgery in cirrhotic patients. J Am Coll Surg. 2009;208(1):96–103. doi:10.1016/j.jamcollsurg.2008.09.006.
  • Mansour A, Watson W, Shayani V, et al. Abdominal operations in patients with cirrhosis: still a major surgical challenge. Surgery. 1997;122(4):730–735. discussion 735–736. doi:10.1016/S0039-6060(97)90080-5.
  • Neeff HP, Streule GC, Drognitz O, et al. Early mortality and long-term survival after abdominal surgery in patients with liver cirrhosis. Surgery. 2014;155(4):623–632. doi:10.1016/j.surg.2013.11.009.
  • Shiloach M, Frencher SK, Steeger JE, et al. Toward robust information: data quality and inter-rater reliability in the American College of Surgeons National Surgical Quality Improvement Program. J Am Coll Surg. 2010;210(1):6–16. doi:10.1016/j.jamcollsurg.2009.09.031.
  • Pitt HA, Kilbane M, Strasberg SM, et al. ACS-NSQIP has the potential to create an HPB-NSQIP option. HPB (Oxford). 2009;11(5):405–413. doi:10.1111/j.1477-2574.2009.00074.x.
  • Gupta H, Ramanan B, Gupta PK, et al. Impact of COPD on postoperative outcomes: results from a national database. Chest. 2013;143(6):1599–1606. doi:10.1378/chest.12-1499.
  • Parkes J, Guha IN, Roderick P, et al. Performance of serum marker panels for liver fibrosis in chronic hepatitis C. J Hepatol. 2006;44(3):462–474. doi:10.1016/j.jhep.2005.10.019.
  • Juo Y-Y, Skancke M, Holzmacher J, et al. Laparoscopic versus open ventral hernia repair in patients with chronic liver disease. Surg Endosc. 2017;31(2):769–777. doi:10.1007/s00464-016-5031-6.
  • Henderson WG, Khuri SF, Mosca C, et al. Comparison of risk-adjusted 30-day postoperative mortality and morbidity in Department of Veterans Affairs hospitals and selected university medical centers: general surgical operations in men. J Am Coll Surg. 2007;204(6):1103–1114. doi:10.1016/j.jamcollsurg.2007.02.068.
  • Vaid S. Predicting risk of death in general surgery patients on the basis of preoperative variables using American College of Surgeons National Surgical Quality Improvement Program Data. Perm J. 2012;16(4):10–17. doi:10.7812/TPP/12-019.
  • Harrell FE, Jr, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15(4):361–387. doi:10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4.
  • Steyerberg EW, Harrell FE, Borsboom GJJM, et al. Internal validation of predictive models: Efficiency of some procedures for logistic regression analysis. J Clin Epidemiol. 2001; 54(8):774–781. doi:10.1016/S0895-4356(01)00341-9.
  • Parsons LS. Performing a 1:N Case-Control Match on Propensity Score. 2004. [cited 2014 5/15/2014]; Available from: http://www2.sas.com/proceedings/sugi29/165-29.pdf.
  • Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383. doi:10.1016/0021-9681(87)90171-8.
  • Jepsen P, Vilstrup H, Andersen PK, et al. Comorbidity and survival of Danish cirrhosis patients: a nationwide population-based cohort study. Hepatology. 2008;48(1):214–220. doi:10.1002/hep.22341.
  • Lambert D. Zero-inflated poisson regression, with an application to defects in manufacturing. Technometrics. 1992;34(1):1–14. doi:10.2307/1269547.
  • Ferenci P, Lockwood A, Mullen K, et al. Hepatic encephalopathy–definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology. 2002;35(3):716–721. doi:10.1053/jhep.2002.31250.
  • Northup PG, McMahon MM, Ruhl AP, et al. Coagulopathy does not fully protect hospitalized cirrhosis patients from peripheral venous thromboembolism. Am J Gastroenterol. 2006;101(7):1524–1528. quiz 1680. doi:10.1111/j.1572-0241.2006.00588.x.
  • Arroyo V, Guevara M, Ginès P. Hepatorenal syndrome in cirrhosis: pathogenesis and treatment. Gastroenterology. 2002;122(6):1658–1676. doi:10.1053/gast.2002.33575.
  • El-Serag HB, Tran T, Everhart JE. Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology. 2004;126(2):460–468. doi:10.1053/j.gastro.2003.10.065.
  • Kavoliuniene A, Vaitiekiene A, Cesnaite G. Congestive hepatopathy and hypoxic hepatitis in heart failure: a cardiologist's point of view. Int J Cardiol. 2013;166(3):554–558. doi:10.1016/j.ijcard.2012.05.003.
  • Ghaferi AA, Mathur AK, Sonnenday CJ, et al. Adverse outcomes in patients with chronic liver disease undergoing colorectal surgery. Ann Surg. 2010;252(2):345–350. doi:10.1097/SLA.0b013e3181e982d6.
  • Shaheen AAM, Kaplan GG, Hubbard JN, et al. Morbidity and mortality following coronary artery bypass graft surgery in patients with cirrhosis: a population-based study. Liver Int. 2009;29(8):1141–1151. doi:10.1111/j.1478-3231.2009.02058.x.
  • Nguyen GC, Correia AJ, Thuluvath PJ. The impact of cirrhosis and portal hypertension on mortality following colorectal surgery: a nationwide, population-based study. Dis Colon Rectum. 2009;52(8):1367–1374. doi:10.1007/DCR.0b013e3181a80dca.
  • Carbonell AM, Wolfe LG, DeMaria EJ. Poor outcomes in cirrhosis-associated hernia repair: a nationwide cohort study of 32,033 patients. Hernia. 2005;9(4):353–357. doi:10.1007/s10029-005-0022-x.
  • Bajaj JS, O'Leary JG, Wong F, et al. Bacterial infections in end-stage liver disease: current challenges and future directions. Gut. 2012;61(8):1219–1225. doi:10.1136/gutjnl-2012-302339.
  • Aldawood A, Arabi Y, Aljumah A, et al. The incidence of venous thromboembolism and practice of deep venous thrombosis prophylaxis in hospitalized cirrhotic patients. Thrombosis J. 2011;9(1):1. doi:10.1186/1477-9560-9-1.
  • Salerno F, Gerbes A, Ginès P, et al. Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis. Gut. 2007;56(9):1310–1318. doi:10.1136/gut.2006.107789.
  • Azoulay D, Buabase F, Damiano I, et al. Neoadjuvant transjugular intrahepatic portosystemic shunt: a solution for extrahepatic abdominal operation in cirrhotic patients with severe portal hypertension. J Am Coll Surg. 2001;193(1):46–51. doi:10.1016/S1072-7515(01)00911-5.
  • Schlenker C, Johnson S, Trotter JF. Preoperative transjugular intrahepatic portosystemic shunt (TIPS) for cirrhotic patients undergoing abdominal and pelvic surgeries. Surg Endosc. 2009;23(7):1594–1598. doi:10.1007/s00464-009-0405-7.
  • Vinet E, Perreault P, Bouchard L, et al. Transjugular intrahepatic portosystemic shunt before abdominal surgery in cirrhotic patients: a retrospective, comparative study. Can J Gastroenterol. 2006;20(6):401–404. doi:10.1155/2006/245082.
  • Quan H, Li B, Duncan Saunders L, et al. Assessing validity of ICD-9-CM and ICD-10 administrative data in recording clinical conditions in a unique dually coded database. Health Serv Res. 2008;43(4):1424–1441. doi:10.1111/j.1475-6773.2007.00822.x.
  • Dindo D, Demartines N, Clavien P-A. Classification of surgical complications. Ann Surg. 2004;240(2):205–213. doi:10.1097/01.sla.0000133083.54934.ae.
  • Slankamenac K, Graf R, Barkun J, et al. The comprehensive complication index: a novel continuous scale to measure surgical morbidity. Ann Surg. 2013;258(1):1–7. doi:10.1097/SLA.0b013e318296c732.
  • Porembka MR, Hall BL, Hirbe M, et al. Quantitative weighting of postoperative complications based on the accordion severity grading system: demonstration of potential impact using the american college of surgeons national surgical quality improvement program. J Am Coll Surg. 2010;210(3):286–298. doi:10.1016/j.jamcollsurg.2009.12.004.
  • Strasberg SM, Hall BL. Postoperative morbidity index: a quantitative measure of severity of postoperative complications. J Am Coll Surg. 2011;213(5):616–626. doi:10.1016/j.jamcollsurg.2011.07.019.
  • Kothari P, Congiusta DV, Merchant AM. Laparoscopic versus open colectomy: the impact of frailty on outcomes. Updates Surg. 2019;71(1):89–96. doi:10.1007/s13304-018-0531-7.
  • Akyar S, Armenia SJ, Ratnani P, et al. The impact of frailty on postoperative cardiopulmonary complications in the emergency general surgery population. Surg J. (N Y). 2018;4(2):e66–e77. doi:10.1055/s-0038-1655756.
  • Congiusta DV, Palvannan P, Merchant AM. The impact of frailty on morbidity and mortality following open emergent colectomies. Biomed Res Int. 2017;2017:1. doi:10.1155/2017/5126452.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.